ZNF786: A Potential Drug Target for Neurological and Psychiatric Disorders

ZNF786: A Potential Drug Target for Neurological and Psychiatric Disorders

ZNF786 (ZN786_HUMAN), a protein that belongs to the ZNF family, plays a crucial role in the development and maintenance of neural tissues, including brain and spinal cord. ZNF786 has been identified as a potential drug target and biomarker for various neurological and psychiatric disorders.

The ZNF family of proteins is known for their ability to regulate gene expression and cell signaling. ZNF786 is a 21-kDa protein that is expressed in various tissues, including brain, heart, and pancreas. It is characterized by a N-terminal transmembrane domain, a T-loop region, and a C-terminal cytoplasmic domain. ZNF786 is a potent inhibitor of the transcription factor, NF-kappa-B, and has been shown to promote the degradation of NF-kappa-B-regulated genes.

ZNF786 has been shown to play a role in various neurological and psychiatric disorders. For example, ZNF786 has been linked to the development of several neurological disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia. ZNF786 has also been shown to be involved in the pathophysiology of various psychiatric disorders, such as depression and anxiety.

One of the key features of ZNF786 is its ability to interact with other proteins. ZNF786 can form a complex with several other proteins, including NF-kappa-B, p53, andCREB. These interactions may play a role in the regulation of gene expression and cell signaling. ZNF786 has also been shown to interact with small molecules, such as inhibitors of NF-kappa-B signaling.

In addition to its role in neurological and psychiatric disorders, ZNF786 has also been shown to be a potential biomarker for these conditions. For example, ZNF786 has been shown to be decreased in the brains of individuals with Alzheimer's disease, and it has been linked to the expression of genes involved in neurodegeneration. Similarly, ZNF786 has been shown to be decreased in the blood of individuals with major depressive disorder, and it has been linked to the expression of genes involved in mood regulation.

The potential utility of ZNF786 as a drug target or biomarker makes it an attractive target for research into the treatment of neurological and psychiatric disorders. ZNF786 has been shown to be involved in the regulation of a wide range of genes, and it is possible that inhibiting its activity may be a effective way to treat these disorders. Additionally, the ability of ZNF786 to interact with other proteins and small molecules makes it a potential target for small molecule inhibitors.

While further research is needed to fully understand the role of ZNF786 in neurological and psychiatric disorders, its potential as a drug target or biomarker is an exciting area of study. ZNF786 may be a valuable tool for the development of new treatments for a wide range of neurological and psychiatric disorders.

Protein Name: Zinc Finger Protein 786

Functions: May be involved in transcriptional regulation

More Common Targets

ZNF787 | ZNF788P | ZNF789 | ZNF79 | ZNF790 | ZNF790-AS1 | ZNF791 | ZNF792 | ZNF793 | ZNF799 | ZNF8 | ZNF8-ERVK3-1 | ZNF80 | ZNF800 | ZNF804A | ZNF804B | ZNF805 | ZNF807P | ZNF808 | ZNF81 | ZNF812P | ZNF813 | ZNF814 | ZNF815P | ZNF816 | ZNF816-ZNF321P | ZNF818P | ZNF821 | ZNF823 | ZNF826P | ZNF827 | ZNF829 | ZNF83 | ZNF830 | ZNF831 | ZNF833P | ZNF835 | ZNF836 | ZNF837 | ZNF839 | ZNF839P1 | ZNF84 | ZNF840P | ZNF841 | ZNF843 | ZNF844 | ZNF845 | ZNF846 | ZNF85 | ZNF850 | ZNF852 | ZNF853 | ZNF860 | ZNF862 | ZNF865 | ZNF875 | ZNF876P | ZNF878 | ZNF879 | ZNF880 | ZNF883 | ZNF887P | ZNF888 | ZNF890P | ZNF891 | ZNF90 | ZNF91 | ZNF92 | ZNF93 | ZNF962P | ZNF98 | ZNF99 | ZNFX1 | ZNG1A | ZNG1B | ZNG1C | ZNG1E | ZNG1F | ZNHIT1 | ZNHIT2 | ZNHIT3 | ZNHIT6 | ZNRD2 | ZNRD2-DT | ZNRF1 | ZNRF2 | ZNRF2P1 | ZNRF3 | ZNRF3-AS1 | ZNRF4 | ZP1 | ZP2 | ZP3 | ZP4 | ZPBP | ZPBP2 | ZPLD1 | ZPLD2P | ZPR1 | ZRANB1